Pharmas to evolve and innovate in 2010

You need Adobe Flash player to view this content.
You can download it the flash player here

Register now to view this content

Now playing

  • Aamer Nawid, Analyst, Fat Prophets

    Aamer Nawid, Analyst, Fat Prophets

Video sections

As market uncertainty continues, large-cap defensive shares such as AstraZeneca and GlaxoSmithKline will continue to attract back investors looking for a decent dividend yield, explains Aamer Nawid.

By viewing the video or accessing the transcript you are agreeing to accept the Cantos Terms and Conditions.

Bookmark & share:

Sign up to Our Newsletters